Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5100
-0.0100 (-1.92%)
Apr 30, 2026, 2:56 PM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 26.44 million as of May 1, 2026. Its market cap has decreased by -16.74% in one year.
Market Cap
26.44M
Enterprise Value
22.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 26.44M, an increase of 89.44%. That is a compound annual growth rate of 17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 26.44M | -21.54% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 47.55M |
| Quantum BioPharma | 45.47M |
| BriaCell Therapeutics | 40.02M |
| Defence Therapeutics | 39.31M |
| MedMira | 38.60M |
| Telescope Innovations | 35.55M |
| Microbix Biosystems | 34.51M |
| Devonian Health Group | 33.09M |